Refining human T-cell immunotherapy of cytomegalovirus disease: a mouse model with ‘humanized’ antigen presentation as a new preclinical study tool-Reference-Cited by-同舟云学术

Refining human T-cell immunotherapy of cytomegalovirus disease: a mouse model with ‘humanized’ antigen presentation as a new preclinical study tool

Published:2016-08-18 Issue:6 Volume:205 Page:549-561
ISSN:0300-8584
Container-title:Medical Microbiology and Immunology
language:en
Short-container-title:Med Microbiol Immunol

Author:

Lemmermann Niels A. W.,Reddehase Matthias J.

Funder

Deutsche Forschungsgemeinschaft

Publisher

Springer Science and Business Media LLC

Subject

Microbiology (medical),Immunology,General Medicine,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00430-016-0471-0.pdf

Reference101 articles.

1. Cannon MJ, Grosse SD, Fowler KB (2013) The epidemiology and public health impact of congenital cytomegalovirus infection. In: Reddehase MJ (ed) Cytomegaloviruses: from molecular pathogenesis to intervention, chapter 2, vol II. Caister Academic Press, Norfolk, pp 26–48

2. Boppana SB, Britt WJ (2013) Synopsis of clinical aspects of human cytomegalovirus disease. In: Reddehase MJ (ed) Cytomegaloviruses: from molecular pathogenesis to intervention, chapter 1, vol II. Caister Academic Press, Norfolk, pp 1–25

3. Ho M (2008) The history of cytomegalovirus and its diseases. Med Microbiol Immunol 197:65–73

4. Adler SP, Nigro G (2013) Clinical cytomegalovirus research: congenital infection. In: Reddehase MJ (ed) Cytomegaloviruses: from molecular pathogenesis to intervention, chapter 3, vol II. Caister Academic Press, Norfolk, pp 55–72

5. Reddehase MJ (2002) Antigens and immunoevasins: opponents in cytomegalovirus immune surveillance. Nat Rev Immunol 2:831–844

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk factors and incidence of cytomegalovirus viremia and disease in pediatric patients with allogeneic hematopoietic stem cell transplantation: An 8‐year single‐center experience in Latin America;Pediatric Transplantation;2022-06

2. Therapeutic Vaccination of Hematopoietic Cell Transplantation Recipients Improves Protective CD8 T-Cell Immunotherapy of Cytomegalovirus Infection;Frontiers in Immunology;2021-08-19

3. Enhancement of Antigen Presentation by Deletion of Viral Immune Evasion Genes Prevents Lethal Cytomegalovirus Disease in Minor Histocompatibility Antigen-Mismatched Hematopoietic Cell Transplantation;Frontiers in Cellular and Infection Microbiology;2020-06-09

4. The CD4+ T Cell Response to Human Cytomegalovirus in Healthy and Immunocompromised People;Frontiers in Cellular and Infection Microbiology;2020-05-19

5. Insufficient Antigen Presentation Due to Viral Immune Evasion Explains Lethal Cytomegalovirus Organ Disease After Allogeneic Hematopoietic Cell Transplantation;Frontiers in Cellular and Infection Microbiology;2020-04-15